Prescription medicine
Chromic
Chromic is a prescription medicine with an FDA approval on record since 1986. FDA's NDC Directory lists it from 1 generic labeler.
- Generic listed
Check it at the source: the chromic FDA label on DailyMed (effective June 24, 2026, Hospira, Inc.); the NDA 18961 record on Drugs@FDA; every chromic label on DailyMed.
Highlights of the record
FDA label of June 24, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageChromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for TPN.
Forms and strengths
Injection (solution).
On the market
- Earliest approval on file
- June 26, 1986 Chromic Chloride In Plastic Container, Hospira; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- 1 first November 18, 2024; 1 with a marketed status in Drugs@FDA
- Labelers listed (NDC)
- 2 of which 1 under generic applications, 1 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 850 through July 30, 2026
What is chromic used for?
From the label: indications and usageChromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for TPN. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
Source: FDA drug label (Chromium), Hospira, Inc., effective June 24, 2026 (SPL set da207ca8-7836-4c66-92fe-36cc89baf773), via openFDA; the full label on DailyMed
Is there a generic for chromic?
The FDA approved the first generic chromic on November 18, 2024. 1 generic application is approved; 1 of it carries a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.
FDA's NDC Directory lists chromic from 1 labeler under a generic (ANDA) application and from 1 brand labeler. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
- 1986 earliest approval on file
- 2024 first generic approved
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do FAERS reports show for chromic?
The FDA Adverse Event Reporting System holds 850 reports that list chromic among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 25 are coded as a death and 185 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Chromic side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other